MRK · 10-Q · 2026Q3 · Full report
German Health-Care Reform
Merck & Co., Inc. · 2026-11-04 · Importance 46 · Surprise 42 · In source text
Germany’s parliament approved the Statutory Health Insurance Contribution Rate Stabilization Act (GKV-BStabG) in July 2026. Most provisions take effect on January 1, 2027, and the company says the law will exert significant downward pressure on revenues in Germany, particularly for Keytruda. Merck is evaluating the law’s business implications.
Key facts
- The German parliament approved the GKV-BStabG in July 2026; most provisions take effect January 1, 2027, and Merck expects significant downward pressure on German revenues, particularly Keytruda. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | probable | — | The German parliament approved the GKV-BStabG in July 2026; most provisions take effect January 1, 2027, and Merck expects significant… |